Literature DB >> 24719315

COL6A3 expression in adipocytes associates with insulin resistance and depends on PPARγ and adipocyte size.

Simon N Dankel1, Jessica Svärd, Simone Matthä, Melina Claussnitzer, Nora Klöting, Viktoria Glunk, Zinayida Fandalyuk, Elise Grytten, Margit H Solsvik, Hans-Jørgen Nielsen, Christian Busch, Hans Hauner, Matthias Blüher, Thomas Skurk, Jørn V Sagen, Gunnar Mellgren.   

Abstract

OBJECTIVE: COL6A3 may modulate adipose tissue function in obesity and insulin resistance. A role for human adipocytes linking COL6A3 with insulin resistance warrants exploration.
METHODS: COL6A3 mRNA in abdominal subcutaneous adipose samples was compared between (1) BMI-matched obese subjects resistant or sensitive to insulin (surgical whole tissue biopsies, n = 30/group), (2) lean/overweight and obese subjects (isolated adipocytes from collagenase-treated surgical biopsies, n = 11/group), (3) developing primary human adipocytes with/without knockdown of the insulin-sensitizing adipogenic gene PPARG (collagenase-treated lipoaspirate, n = 5), and (4) small and large adipocytes from lean/overweight subjects (collagenase-treated surgical biopsies or lipoaspirate, n = 10). Insulin resistance and sensitivity were assessed by euglycemic-hyperinsulinemic clamp (glucose infusion rate <60 and >70 μmol kg(-1) min(-1) , respectively) (1), or by HOMA-IR and TG/HDL ratio (2).
RESULTS: Whole tissue COL6A3 mRNA was 2.6-fold higher in insulin resistant compared to sensitive subjects (P < 0.001). In isolated adipocytes, COL6A3 mRNA correlated positively with BMI (P = 0.007), HOMA-IR (P = 0.039), and TG/HDL (P = 0.004). PPARG knockdown in developing adipocytes increased COL6A3 mRNA 1.5-fold (P = 0.043). The inverse relationship with adipocyte development was further supported by 2.8-fold higher COL6A3 mRNA in small compared to large adipocytes (P = 0.004).
CONCLUSION: Increased adipocyte COL6A3 expression associates with insulin resistance in humans, which may involve impaired PPARγ-mediated adipocyte development.
© 2014 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24719315     DOI: 10.1002/oby.20758

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  33 in total

1.  Adipose tissue fibrosis, hypertrophy, and hyperplasia: Correlations with diabetes in human obesity.

Authors:  Lindsey A Muir; Christopher K Neeley; Kevin A Meyer; Nicki A Baker; Alice M Brosius; Alexandra R Washabaugh; Oliver A Varban; Jonathan F Finks; Brian F Zamarron; Carmen G Flesher; Joshua S Chang; Jennifer B DelProposto; Lynn Geletka; Gabriel Martinez-Santibanez; Niko Kaciroti; Carey N Lumeng; Robert W O'Rourke
Journal:  Obesity (Silver Spring)       Date:  2016-03       Impact factor: 5.002

2.  Serum endotrophin identifies optimal responders to PPARγ agonists in type 2 diabetes.

Authors:  Morten A Karsdal; Kim Henriksen; Federica Genovese; Diana J Leeming; Mette J Nielsen; Bente J Riis; Claus Christiansen; Inger Byrjalsen; Detlef Schuppan
Journal:  Diabetologia       Date:  2016-09-08       Impact factor: 10.122

Review 3.  The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis.

Authors:  Clair Crewe; Yu Aaron An; Philipp E Scherer
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

Review 4.  Adipocyte dysfunction, inflammation and metabolic syndrome.

Authors:  Nora Klöting; Matthias Blüher
Journal:  Rev Endocr Metab Disord       Date:  2014-12       Impact factor: 6.514

5.  Repression of Adipose Tissue Fibrosis through a PRDM16-GTF2IRD1 Complex Improves Systemic Glucose Homeostasis.

Authors:  Yutaka Hasegawa; Kenji Ikeda; Yong Chen; Diana L Alba; Daniel Stifler; Kosaku Shinoda; Takashi Hosono; Pema Maretich; Yangyu Yang; Yasushi Ishigaki; Jingyi Chi; Paul Cohen; Suneil K Koliwad; Shingo Kajimura
Journal:  Cell Metab       Date:  2018-01-09       Impact factor: 27.287

6.  Adipocyte size, adipose tissue fibrosis, macrophage infiltration and disease risk are different in younger and older individuals with childhood versus adulthood onset obesity.

Authors:  L Turner; M-F Gauthier; A Lafortune; A Tchernof; S Santosa
Journal:  Int J Obes (Lond)       Date:  2022-08-04       Impact factor: 5.551

7.  Relevance of omental pericellular adipose tissue collagen in the pathophysiology of human abdominal obesity and related cardiometabolic risk.

Authors:  A Michaud; J Tordjman; M Pelletier; Y Liu; S Laforest; S Noël; G Le Naour; C Bouchard; K Clément; A Tchernof
Journal:  Int J Obes (Lond)       Date:  2016-10-04       Impact factor: 5.095

Review 8.  Metabolically healthy obesity: facts and fantasies.

Authors:  Gordon I Smith; Bettina Mittendorfer; Samuel Klein
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

9.  Increased Adipose Tissue Fibrogenesis, Not Impaired Expandability, Is Associated With Nonalcoholic Fatty Liver Disease.

Authors:  Joseph W Beals; Gordon I Smith; Mahalakshmi Shankaran; Anja Fuchs; George G Schweitzer; Jun Yoshino; Tyler Field; Marcy Matthews; Edna Nyangau; Darya Morozov; Bettina Mittendorfer; Marc K Hellerstein; Samuel Klein
Journal:  Hepatology       Date:  2021-06-22       Impact factor: 17.425

Review 10.  Towards an understanding of the mechanoreciprocity process in adipocytes and its perturbation with aging.

Authors:  Maria De Luca; Maurizio Mandala; Giuseppina Rose
Journal:  Mech Ageing Dev       Date:  2021-06-18       Impact factor: 5.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.